PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female

Urology. 2021 Feb:148:113-117. doi: 10.1016/j.urology.2020.11.024. Epub 2020 Nov 21.

Abstract

PTEN Hamartoma-Tumor-Syndrome (PHTS) describes a series of conditions characterized by germline-mutation of the PTEN tumor-suppressor gene. PHTS patients have an increased lifetime risk of multiple malignancies, including thyroid, breast, and endometrial cancers. PHTS patients also have 20-30 fold increased risk of renal cell carcinoma (RCC) compared to age-matched controls. As with many hereditary RCC syndromes, tumors present early and multifocally. We present a case of one of the youngest patients diagnosed with RCC in PHTS and review the urologic implications of this syndrome.

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Renal Cell / diagnostic imaging
  • Carcinoma, Renal Cell / genetics*
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / surgery
  • Female
  • Hamartoma Syndrome, Multiple / diagnosis
  • Hamartoma Syndrome, Multiple / genetics*
  • Humans
  • Kidney Neoplasms / diagnostic imaging
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery
  • Mutation, Missense*
  • PTEN Phosphohydrolase / genetics*
  • Young Adult

Substances

  • PTEN Phosphohydrolase
  • PTEN protein, human